# LumiMeds reviews (2026): GLP-1 telehealth sellers | This GLP

The ingredient, route and pharmacy type are all stated; the plan behind the price is not.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/lumimeds
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Labeled product, unlabeled term

# LumiMeds review

The ingredient, route and pharmacy type are all stated; the plan behind the price is not.

## The verdict

LumiMeds publishes semaglutide as low as $89 a month and tirzepatide as low as $125. Four plan lengths are offered. Which one the figure belongs to is never said.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

Dose pricing

Flat across doses

From

From $89/mo

Dose published

No

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

LegitScript

Claimed by provider

LumiMeds sells two compounded GLP-1 lines and an NAD+ line. Each has a product page of its own. The pages are built as spec sheets rather than sales copy.

1.  ## Who writes the prescription, and what do they see?
    
    A licensed clinician reviews the intake and prescribes only where appropriate. LumiMeds states there are no auto-approvals and promises a full refund where a buyer is not eligible. Providers are described as United States licensed. None is named, and no state list is published.
    
    Dose changes, refills and questions are described as part of the plan rather than add-ons. Shipping is cold-chain and included. Klarna will split any plan into payments, and FSA and HSA cards are accepted on some of them.
    
2.  ## What happens when the dose goes up?
    
    LumiMeds states there is no upcharge when the dose goes up, which settles the money question. The product page calls the dosing provider-titrated and once weekly. No milligram is printed, so the ladder itself stays out of view.
    
3.  ## What the price includes
    
    The floor is $89 for semaglutide and $125 for tirzepatide. Above those figures sits one line: monthly, three, six and twelve-month options are available. Nothing connects the figure to a term. A buyer cannot tell from the page whether $89 is a month-to-month rate or a year bought at once.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded by a 503A pharmacy against an individual prescription. Compounded drugs are not FDA-approved as a finished product, which LumiMeds states itself. The pharmacy is identified by type rather than by name. The [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) page names the active ingredient, its receptor class, the subcutaneous route and the multi-dose vial it ships in.
    

## Where it holds up, and where it does not

-   Strength: Active ingredient and drug class named on the page
-   Strength: Route, frequency and vial format labeled
-   Strength: The 503A pharmacy type is stated
-   Strength: LegitScript certification is claimed
-   Strength: No upcharge when the dose rises
-   Limitation: The plan term behind the price is not stated
-   Limitation: No milligram appears on either product page
-   Limitation: The pharmacy is named by type only
-   Limitation: A three-week onset claim carries no source

## What the evidence says about this kind of treatment

The assessment above is about LumiMeds. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A buyer who wants the ingredient, route and pharmacy type stated before paying.

Wrong for

A buyer who needs to know what a single month costs before committing.

## The evidence behind what LumiMeds prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How LumiMeds compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Mondae | Buyers who want a low published compounded rate and few other details |  |
| NativeMed | Buyers who want to see the prepay arithmetic before deciding it is a saving |  |
| Spry | Buyers who can read a four-week billing cycle as thirteen charges rather than twelve |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Livbetr](https://thisglp.com/reviews/livbetr) [Longevity Meds](https://thisglp.com/reviews/longevity-meds) [Loozy](https://thisglp.com/reviews/loozy) [Male Excel](https://thisglp.com/reviews/male-excel) [MangoRx](https://thisglp.com/reviews/mangorx) [MD Trim Clinic](https://thisglp.com/reviews/md-trim-clinic)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Is $89 a monthly price?

Not established. The page offers monthly, three, six and twelve-month plans and does not say which the figure buys.

Does the charge rise with the dose?

No. LumiMeds states there is no upcharge when the dose goes up.

Is the pharmacy named?

It is identified as a state-licensed 503A compounding pharmacy. No name is given.

Is LumiMeds expensive compared with other GLP-1 telehealth sellers?

LumiMeds publishes a starting figure of $89/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts LumiMeds below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
